A patient training for a hiking trip and another who spends most of the week sitting at a desk can both report knee stiffness during an office visit. What a sports medicine practitioner recommends next often depends on what that patient plans to do with their joints over the following months.
Joint health supplementation has long been dominated by two ingredients: glucosamine and chondroitin. Decades of published research on that pairing have produced mixed results, a pattern documented across multiple meta-analyses, including one in the Cochrane Library and another in the Journal of Orthopaedic Surgery and Research. Against that backdrop, Cartigenix HP® with RestorCel™, from the supplement company Calroy Health Sciences, has drawn attention for its formulation built around two specific botanical actives, studied together rather than separately.
What Makes a Joint Health Supplement Worth Recommending to Active Patients
Active patients ask practical questions. They want to know whether joint health supplements will help them get through a shift at work or hold up over a season of court sports. Before making a recommendation, practitioners fielding those questions typically look at the formulas and how they’ve been tested in people.
RestorCel is built around serratol from Boswellia serrata and a standardized North India celery seed extract, selected for their synergistic ability to support cartilage regeneration, joint comfort, and healthy mobility.* Combined with eleven additional bioactive compounds, the formula is the basis of the clinical case behind Cartigenix HP with RestorCel.
Serratol from Boswellia Serrata
Boswellia serrata, commonly known as Indian frankincense, has one of the more established research histories among joint-focused botanicals. Concentrations of boswellic acids vary considerably by species and by extraction method, which is why potency disclosure separates a formulated extract from a generic botanical listed on a label without further detail.
In RestorCel, the Boswellia component is standardized via HPLC-PDA to contain at least 40% total boswellic acids, including AKBA, KBA, and BBA, along with serratol and tirucallic acids.
North India Celery Seed Extract
In Cartigenix HP with RestorCel, celery seed extract is standardized for compounds including apiin and 3-n-butylphthalide (3nB) to contribute a distinct mechanism alongside Boswellia. The pairing reflects a broader shift in supplement formulation, and instead of stacking ingredients with overlapping actions, RestorCel combines two botanicals chosen for how they work together on cartilage-relevant endpoints.
Synergy and the 13-Bioactive Design of RestorCel
RestorCel’s 13 bioactives were selected and standardized in precise ratios specifically for their combined effects on cartilage and joint health. This exact combination, at these specifications, exists only in RestorCel.
A supplement built from individually studied ingredients still requires evidence at the level of the finished product, since combining actives can change how they perform together. Cartigenix HP with RestorCel has been evaluated as a complete formulation, not as a set of ingredients extrapolated from separate studies.†
What the Clinical Data Shows for Active Patients
Cartigenix HP has been evaluated in three published human studies, including a randomized, placebo-controlled study. In the studies, participants showed an average 67% reduction in pain scores and a 50% increase in walking distance within 90 days, with measurable cartilage regeneration biomarkers and noticeable improvements as early as 15 days.*† The walking distance improvement speaks to functional mobility, the outcome active patients tend to notice first.
Tom Bayne, DC, an educator with Calroy Health Sciences, frames the role supplementation plays for practitioners this way: “When I work with someone on a joint health protocol, the supplement is one piece, but movement, sleep, and nutrition matter just as much. What I tell patients about Cartigenix HP is that the published research used a 90-day window for a reason. If you’re going to commit to a supplement, commit to giving it the time the studies gave it.”
Sports medicine practitioners, physical therapists, nutritionists, and injury specialists working with active patients rely on that kind of framing when setting expectations. A training season finished without modification and a return to regular activities allows active patients to test a joint health recommendation against everyday life.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
†As shown in a placebo-controlled, randomized, controlled human research study (Vaidya 2025) and an observational study (Desai 2024). A prospective study (n=1,236) similarly demonstrated significant improvements in pain scores, along with quality of life measures (Desai 2022).
FAQs
Question: What should someone look for when choosing a joint-support supplement?
Answer: Look for standardized botanical extracts with disclosed potency levels, ideally backed by research on the finished formulation rather than individual ingredients. Manufacturing standards such as cGMP compliance also indicate consistent quality across batches, which matters for long-term use.
Question: Why do practitioners recommend a 90-day trial for joint supplements?
Answer: Cartilage and connective tissue respond gradually to nutritional support, and most clinical research on joint-focused formulations uses a 90-day window to capture meaningful results. A defined trial period helps patients and practitioners assess whether a supplement is worth continuing.
